What minimum incidence was utilized for reporting toxicities of any grade? |
1 patient, 2-3 patients, 5% incidence, 10% incidence, 15-20% incidence, ≥25% incidence, not reported |
What minimum incidence was utilized for reporting toxicities grade ≥ 3? |
1 patient, 2-3 patients, 5% incidence, 10% incidence, 15-20% incidence, ≥25% incidence, not reported |
Were treatment-related toxicities reported? |
Y/N/Not reported |
Were treatment-emergent toxicities reported? |
Y/N/Not reported |
Was a dose-escalation component included? |
Y/N |
Were adverse events combined across dose levels if dose-escalation was included? |
Y/N |
Were dose-limiting toxicities reported if the trial included a dose-escalation component? |
Y/N |
Were key dose-limiting toxicity criteria described? |
Y/N |
Were serious adverse events reported? |
Y/N |
Were key serious adverse event criteria described? |
Y/N |
Were adverse events leading to treatment change reported? |
Y/N |
Were standardized terminology (CTCAE or MedDRA) utilized? |
Y/N |
Were grouped adverse event terms utilized? |
Y/N |
Was overall incidence of adverse events at organ system level reported? |
Y/N |
Was the total number of patients with any adverse event any grade reported? |
Y/N |
Was the total number of patients with any adverse event grade ≥ 3 reported? |
Y/N |